Alterations in TRPC6 activity following ischemic stroke is likely to alter intracellular Ca2+, that modulates NMDA receptor activity or affects the release of vasoactive mediators, such as nitric oxide (NO) and AA derivatives. This evidence concerns the gene TRPC6 and ischemic stroke.